Clinical Trial Update: Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) [Phase 1, Phase 2]

View source ↗

Summary

An update on the OVATION 2 study evaluating IMNN-001 (GEN-1) with neoadjuvant chemotherapy for epithelial ovarian cancer, fallopian tube cancer, and primary per…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Drugs mentioned

• IMNN-001 (GEN-1)

Snippet

Sponsor: Imunon | Conditions: Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING